Results 151 to 160 of about 162,220 (306)

Studies on alveolar macrophage function in interstitial lung disease

, 1991
Shigee Hosoya
openalex   +2 more sources

Interstitial lung disease in children: a multicentre survey on diagnostic approach [PDF]

, 2000
Angelo Barbato, C. Panizzolo, A.T. Cracco, J. de Blic, R Dinwiddie, M Zach   +5 more
openalex   +1 more source

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

Arthritis &Rheumatology, EarlyView.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim, Se Rim Choi, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park   +5 more
wiley   +1 more source

Pathophysiology and diagnosis of interstitial lung disease. Imaging of interstitial pulmonary diseases.

, 1996
Masashi Sato
openalex   +2 more sources

Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease [PDF]

, 2000
Hirokazu Taniguchi, Shigeki Katoh, Jun‐ichi Kadota, Y Matsubara, Kiyoyasu Fukushima, Hiroshi Mukae, Shigeru Matsukura, S Kohno   +7 more
openalex   +1 more source

Activin A–Activated ALK4 Induces Pathogenic Th17‐Involved Endothelial–Mesenchymal Transition in Systemic Lupus Erythematosus–Associated Pulmonary Arterial Hypertension

Arthritis &Rheumatology, EarlyView.
Objective Autoimmune diseases, such as systemic lupus erythematosus (SLE), are associated with pulmonary arterial hypertension (PAH), a condition that can lead to heart failure. However, whether T cells also contribute to the occurrence of PAH in SLE has not been clarified.
Shuliang Jing, Junyan Qian, Hongjie Ying, Pei Mao, Mingxin Yao, Zhihong Wu, Harm J. Bogaard, Lie Wang, Mengtao Li, Jun Yang   +9 more
wiley   +1 more source

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises. [PDF]

Clin Respir J
Jin H, Song J, Gao R, Sha B, Wang S, Luo P, Yu L, Xu X, Wang X.   +8 more
europepmc   +1 more source

Pulmonary Lymphangitic Sarcomatosis from Cutaneous Angiosarcoma: an Unusual Presentation of Diffuse Interstitial Lung Disease [PDF]

, 2000
Chi‐Ting Liau
openalex   +1 more source

An unusual interstitial lung disease

Annals of Thoracic Medicine, 2012
Jyotsna M Joshi, Dipti Gothi
openaire   +4 more sources

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source